№ files_lp_3_process_9_18430
Supplementary statistical table summarizing published clinical study data on anti-SARS-CoV-2 spike protein IgG seroconversion rates following full COVID-19 vaccination in patients with major hematologic malignancies and in healthy control cohorts across multiple countries.
Document Type: Supplemental table
Topic: Anti-SARS-CoV-2 spike protein IgG seroconversion
Subject: Hematologic malignancies and healthy controls
Medical Context: COVID-19 vaccination response
Vaccines Included: BNT162b2; mRNA1273; Ad26.COV2.S; ChyAdOx1
Antibody Test Platforms: Elecsys; AdviseDx Abbott; Liaison; DBS; Sero-Klir Kantaro; Beckman Coulter; Sino Biological; Meso Scale Discovery; Platelia
Countries Represented: United States; United Kingdom; Israel; Denmark; Italy
Patient Groups: ALL/AML; CLL; CML/MPD; MDS; WM; MM; NHL; Healthy controls
Sample Size Range per Study: 21–650 participants
Combined Healthy Control Sample Size: 729
Primary Outcome Measure: Seroconversion rate after full vaccination
Source Basis: Published and in-press peer-reviewed studies
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.